Last updated on July 2019

A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of baricitinib in combination with topical corticosteroids (TCS) in participants with moderate to severe atopic dermatitis.

Clinical Study Identifier: NCT03733301

Find a site near you

Start Over

Centro de Investigaciones Metab licas (CINME)

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Fundacion CIDEA

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Instituto de Neumonolog a y Dermatolog a

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Psoriahue Medicina Interdisciplinaria

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

The Skin Centre

Benowa, Australia
  Connect »

ULSS 8

Vicenza, Italy
  Connect »

Shirasaki Clinic

Takaoka-shi, Japan
  Connect »

Korea University Ansan Hospital

Ansan-si, Korea, Republic of
  Connect »

Konkuk University Hospital

Seoul, Korea, Republic of
  Connect »

Seoul St. Mary's Hospital

Seoul, Korea, Republic of
  Connect »

Hospital De Gran Canaria Dr. Negrin

Las Palmas de Gran Canaria, Spain
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.